Privia Health Group (NASDAQ:PRVA) Given New $30.00 Price Target at Needham & Company LLC

Privia Health Group (NASDAQ:PRVA) had its target price lifted by research analysts at Needham & Company LLC from $25.00 to $30.00 in a report released on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 20.14% from the company’s current price.

Other equities research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities reaffirmed a “market outperform” rating and issued a $26.00 target price on shares of Privia Health Group in a research note on Friday, February 14th. Stephens reaffirmed an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, Macquarie assumed coverage on shares of Privia Health Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $26.47.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $24.97 on Friday. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $26.04. The stock has a market cap of $3.00 billion, a price-to-earnings ratio of 249.72, a P/E/G ratio of 3.47 and a beta of 0.87. The firm has a fifty day moving average of $22.40 and a 200-day moving average of $20.60.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Quadrant Capital Group LLC raised its holdings in shares of Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after purchasing an additional 511 shares during the last quarter. Park Avenue Securities LLC boosted its position in shares of Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after acquiring an additional 532 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock valued at $140,000 after acquiring an additional 533 shares during the period. First Horizon Advisors Inc. boosted its position in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares during the period. Finally, Summit Investment Advisors Inc. raised its stake in Privia Health Group by 6.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock valued at $209,000 after purchasing an additional 678 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.